Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

BriaCell confirms complete resolution of lung metastasis at 4 months in Phase 1/2a trial using Bria-OTS immunotherapy in ...

Patients with metastatic colorectal cancer who received frontline immune checkpoint inhibitor therapy had positive OS rates ...

Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast ...

"At Castle Biosciences, our commitment to advancing care for melanoma patients helps drive our continuous innovation," said Rebecca Critchley-Thorne, Ph.D., vice president, research and development, ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Breast cancer is the most common cancer in women and the second leading cause of cancer-related deaths after lung cancer.

Brain metastases become more prevalent with each line of therapy in metastatic breast cancer and are more common in patients with certain cancer subtypes, new research shows.

Bangalore-based biotech startup Mestastop Solutions has been awarded the Best Metastasis R&D Specialist for 2025 by the UK-based Global Health and Pharma Group (GHP). This is the fourth time in a ...

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

ASI has announced the introduction of a new Pathology Tumor Detection model that could detect lymph node metastasis.